RxDoctor Payments Data

David Chang

Plastic and Reconstructive Surgery · Chicago, ILNPI 1285732172

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Kls-martin L.p. at 59.2% of the total. Reporting peaked in 2023 at $2,981 and has fallen 85.7% since, to $426 in 2025.

$5,609in general payments, 2019–2025

Across 17 payments — averaging $329.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kls-martin L.p.$3K
  • Baxter Healthcare$769
  • Abbott$364
  • Tepha Inc$275
  • Galderma Laboratories, L.p.$193
  • Access Pro Medical, LLC$155
  • plus $534 from 4 others

What the payments were for

  • Consulting fees$76914%
  • Speaking & faculty fees$2,50045%
  • Travel & lodging$82015%
  • Food & beverage$1,52027%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,609 in reported general payments places this provider in the 70th percentile of 126 plastic and reconstructive surgery providers in Illinois.

See all plastic and reconstructive surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$35,336
Medicare patients
41
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →